Multiplikator Forward P/S: InMode (INMD)
The expected P/S ratio demonstrates a trend where 1.90 records a new level. Aggressive sales and high bonuses for B2B specialists support this growth. High profitability allows InMode Ltd. (INMD) to maintain its staff of Israeli development engineers. Business efficiency is based on strict cost control and the regular release of innovative radiofrequency devices for aesthetic medicine.
Ringkesan rincian data analitis InMode MD (INMD)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal InMode Ltd.|INMD - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal InMode Ltd.|INMD - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku InMode MD|INMD - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan InMode|Rasio cepet inmodemd.com
- rincian asil keuangan lan kelipatan valuasi:
INMD - Penghasilan resik perusahaan|Bathi sing dikarepake InMode Ltd.|INMD - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi InMode Corp|INMD - Pangali PEG|Pangali EV/EBITDA InMode MD|INMD - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan InMode|INMD - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan inmodemd.com|INMD - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep InMode Ltd.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:INMD (InMode)
InMode Ltd. is transforming aesthetic medicine through minimally invasive radiofrequency technologies, which directly impacts expected sales dynamics. The forward P/S ratio compares the current market value of the business with projected annual revenue, revealing whether the asset is overvalued or undervalued. This indicator measures market expectations, allowing investors to identify entry points when multiples are depressed. The history of forward P/S changes helps synchronize capitalization with the actual pace of innovation expansion.
Karo sapa InMode Ltd. saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S PMI|Multiplikator forward rega marang pendapatan Surmodics Inc. SRDX|Multiplikator Forward P/S SENS (Senseonics Holdings)|Multiplikator Forward P/S neuropace.com NPCE|TCMD - Rasio rega marang prakiraan pendapatan|SNWV: Rasio rega marang prakiraan pendapatan|OM (Outset) - Multiplikator forward rega marang pendapatan|Electromed - Rega forward marang dodolan|LNSR (LENSAR, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep avitamedical.com RCEL|Rasio rega marang prakiraan pendapatan Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Prakiraan rega marang pendapatan|EDAP TMS - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Apyx Medical Corp APYX|IceCure Medical, Ltd. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Pulmonx Corporation LUNG|telabio.com (TELA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CTSO (CytoSorbents Corporation)|Rasio rega marang prakiraan pendapatan Sensus Healthcare Corp|Multiplikator forward rega marang pendapatan Zynex Corp (ZYXI)|Multiplikator Forward P/S ECOR|RBOT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Inspira Technologies IINN|ICU: Kapitalisasi marang prakiraan pendapatan|IRIX: Multiplikator forward rega marang pendapatan|Intelligent Bio Solutions - Rasio rega marang pendapatan sing dikarepake|XAIR: Multiplikator Forward P/S|PFSA - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan STRATA Skin Sciences Inc.|Kapitalisasi marang prakiraan pendapatan GCTK (glucotrack.com)|Rasio rega marang prakiraan pendapatan NanoVibronix (NAOV)|Multiplikator forward rega marang pendapatan Venus Concept Corporation VERO|Rasio rega marang prakiraan pendapatan Nuwellis, Inc. NUWE|aethlonmedical.com (AEMD) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|TransEnterix - Multiplikator Forward P/S|AVGR (Avinger Inc.) - Kapitalisasi marang prakiraan pendapatan|BSGM: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Cutera Inc (CUTR)|Multiplikator forward rega marang pendapatan KNW|NARI: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Nevro (NVRO)|Rasio rega marang prakiraan pendapatan RSLS (reshapelifesciences.com)|Silk Road Medical Inc. - Multiplikator forward rega marang pendapatan
